Bright Health Group, Inc. Stock News

A Deadline is coming up on March 7, 2022 in the lawsuit for certain investors in Bright Health Group, Inc. (NYSE:BHG). San Diego, CA -- ( SBWIRE ) -- 03/07/2022 -- A deadline is coming up on March 7, 2022 in the lawsuit filed for certain investors of Bright Health Group, Inc. (NYSE: BHG). Investors who purchased shares of Bright Health Group, Inc. (NYSE: BHG) have certain options and there are strict and short deadlines running. Deadline: March 7, 2022. NYSE: BHG stockholders should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The plaintiff alleges on behalf of purchasers of Bright Health Group, Inc. (NYSE: BHG) common shares between June 24, 2021 and November 10, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

SAN FRANCISCO, March 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Bright Health Group, Inc. (NYSE: BHG ) investors with significant losses to submit your losses now . Class Period: June 21, 2021 – Nov. 10, 2021 Lead Plaintiff Deadline: Mar. 7, 2022 Visit: www.hbsslaw.com/investor-fraud/BHG Contact An Attorney Now: [email protected] 844-916-0895 Bright Health Group, Inc. (BHG) Securities Class Action: The complaint alleges that Bright Health, senior executives and other responsible parties made false and misleading statements during and after the company''s June 2021 initial public offering about the adaptability of the company''s so-called "alignment" business model to continue to deliver improved medical cost ratios ("MCR"), a key metric dependent on capturing certain premium revenues. Specifically, Defendants misrepresented and failed to disclose that Bright Health (1) overstated the company''s post-IPO financial prospects in its offering documents, (2) was … Full story available on Benzinga.

SAN FRANCISCO, March 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Bright Health Group, Inc. (NYSE: BHG) investors with significant losses to submit your losses now .

NEW YORK, March 06, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bright Health Group, Inc. (NYSE: BHG): (i) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s June 24, 2021 initial public offering (the “IPO”); and/or (ii) between June 24, 2021 and November 10, 2021, inclusive (the “Class Period”), of the important March 7, 2022 lead plaintiff deadline .

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming March 7, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s June 2021 initial public offering (“IP

Friday afternoon''s top analyst upgrades and downgrades included Best Buy, Bright Health, Equitrans Midstream, Knight-Swift Transportation, Marvell Technology, Sea Ltd. and Six Flags Entertainment.

SAN DIEGO, March 3, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of: (a) Bright Health Group, Inc. (NYSE: BHG) common stock pursuant and/or traceable to the offering documents issued in connection with Bright Health''s initial public offering conducted on…

Within the last quarter, Bright Health Gr (NYSE: BHG ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 2 3 0 Last 30D 0 2 1 1 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 1 2 0 In the last 3 months, 8 analysts have offered 12-month price targets for Bright Health Gr. The company has an average price target of $4.12 with a high of $5.50 and a low of $2.00. Below is a summary of how these 8 analysts rated Bright Health Gr over the past 3 months. The greater the number of … Full story available on Benzinga.com

Vonage Holdings Corp. (NASDAQ:VG) with the stream of -1.67% also noticed, India Bright Health Group, Inc. (NYSE:BHG) encountered a rapid change of -19.55% in the last hour of Wednesday’s trading … The post Stock that saw a surge of activity: Vonage Holdings Corp. (NASDAQ:VG), Bright Health Group, Inc. (NYSE:BHG) appeared first on Stocks Equity .

CEDARHURST, N.Y.--(BUSINESS WIRE)--The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Bright Health Group, Inc. (NYSE: BHG), if they purchased the Company’s securities between June 24, 2021 and November 10, 2021, inclusive (the “Class Period”) and/or purchased or otherwise acquired the Company’s shares pursuant to the Company’s June 2021 initial public offering (the “IPO”). Shareholders have until March 7, 2022 to file lead plaintiff applications in the

Bright Health Group, Inc.'s (BHG) CEO Mike Mikan on Q4 2021 Results - Earnings Call Transcript

CHARLOTTE, N.C., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Let''s Talk Interactive, Inc. (LTI), a leader in customizable telehealth solutions, is pleased to announce the addition of Korey Keenan as director of sales. Keenan has deep experience in the telehealth industry, having worked with some of the largest healthcare systems, payers, and IDNs in the United States. In his new role, Keenan will leverage his more than 20 years of experience in telehealth to support LTI in bringing virtual care solutions to the enterprise healthcare sector. Keenan joins LTI from Bright Health Group, an insurance technology firm that acquired telemedicine software company Zipnosis in 2021. Prior to the acquisition, Keenan was director of sales at Zipnosis, supporting the growth and adoption of the platform to enterprise healthcare systems. "We are thrilled to welcome Korey Keenan to LTI," said Arthur Cooksey, CEO and founder of Let''s Talk Interactive. "Both Korey and LTI share more than two decades in telehealth.

Bright Health Group (BHG) Chief Executive Officer Simeon Schindelman has decided to resign from his position with effect from March 11.He will be replaced by the companys current

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today a

NEW YORK, Feb. 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Meta Materials, Inc. (NASDAQ: MMAT ), Bright Health Group, Inc. (NYSE: BHG ), First Solar, Inc. (NASDAQ: FSLR ), and Talis Biomedical Corporation (NASDAQ: TLIS ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Meta Materials, Inc. (NASDAQ: MMAT ) Class Period: September 21, 2020 December 14, 2021 Lead Plaintiff Deadline: March 4, 2022 According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose: (1) the business combination of Torchlight Energy Resources, Inc. and Metamaterial Inc. would result in an SEC investigation and subpoena in the matter captioned In the Matter of Torchlight Energy Resources, Inc.; (2) the Company has materially overstated its business connections and dealings; (3) the Company has materially overstated its ability to produce and commercialize its products; (4) the Company has materially overstated its products'' novelty and capabilities; (5) the Company''s products did not have the potential to be disruptive because, among other things, the Company priced its products too high; and (6) as a result, Defendants'' public statements were materially false and/or misleading at all relevant times.